LANANH NGUYEN: Open Payments
NPI 1891338521 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 13 payments from 6 companies in 2025. Trend: 2023 $531 · 2024 $375 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Vifor Pharma, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: Fabhalta, JARDIANCE, Veltassa, Kerendia, JYNARQUE.
Industry payments across GA — which companies pay providers there.
